[1]
I. Halil Ozerol, M. Senol, A. Ageitos, J. E. Talmadge, and PhD, “The effect of interleukin-2 on natural killer activity of bone marrow and peripheral stem cell products from non-hodgkin’s lymphoma patients ”, annalsmedres, vol. 3, no. 3, pp. 0177–0182, May 2021.